نتائج البحث - Alejandro Navarro

تنقيح النتائج
  1. 1
    Angiogenesis, multitarget kinase inhibitors and non-small cell lung cancer: a lesson from MONET1 trial

    Angiogenesis, multitarget kinase inhibitors and non-small cell lung cancer: a lesson from MONET1 trial حسب Mendivil, Alejandro Navarro, Rodriguez, Pablo Martinez, Felip, Enriqueta

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Colombian Creole Horse: Frequency of oral and motor stereotypies

    Colombian Creole Horse: Frequency of oral and motor stereotypies حسب Mejía, Jhonny Alberto Buitrago, Jaramillo, Jairo Alejandro Navarro, Corrales, Natalia Uribe

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Guías actuales de práctica clínica en la diabetes mellitus tipo 2: ¿cómo aplicarlas en atención primaria?

    Guías actuales de práctica clínica en la diabetes mellitus tipo 2: ¿cómo aplicarlas en atención primaria? حسب Navarro Pérez, Jorge, Adam, Alejandro Navarro, Beltrán, Domingo Orozco, Guillén, Vicente Gil, Munuera, Concepción Carratalá

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)

    Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM) حسب S. Cedrés, Santiago Ponce-Aix, Jon Zugazagoitia, Irene Sansano, Ana B. Enguita, Alejandro Navarro, Alex Martínez‐Martí, Pablo Martínez, Enriqueta Felip

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer

    Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer حسب Todd M. Bauer, Alice T. Shaw, Melissa L. Johnson, Alejandro Navarro, Justin F. Gainor, Holger Thurm, Yazdi K. Pithavala, Antonello Abbattista, Gerson Peltz, Enriqueta Felip

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients

    Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients حسب Pablo Martínez, Javier Hernández‐Losa, S. Cedrés, Josep Castellví, Alex Martínez‐Martí, N Tallada, Nuria Murtra-Garrell, Alejandro Navarro-Mendivill, Víctor Rodríguez-Freixinós, Mercedes Canela, Santiago Ramón y Cajal, Enriqueta Felip

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer

    Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer حسب Patricia Iranzo, Ana Callejo, J.D. Assaf, Gaspar Molina, D. López-Valbuena, David García-Illescas, Núria Pardo, Alejandro Navarro, Alex Martínez‐Martí, S. Cedrés, Caterina Carbonell, Joan Frigola, Ramon Amat, Enriqueta Felip

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer

    Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer حسب Shindo, Koji, Yu, Jun, Suenaga, Masaya, Fesharakizadeh, Shahriar, Tamura, Koji, Almario, Jose Alejandro Navarro, Brant, Aaron, Borges, Michael, Siddiqui, Abdulrehman, Datta, Lisa, Wolfgang, Christopher L., Hruban, Ralph H., Klein, Alison Patricia, Goggins, Michael

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment

    ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment حسب Santiago Ponce, S. Cedrés, Charles Ricordel, Nicolás Isambert, Santiago Viteri, Mercedes Herrera, Alex Martínez‐Martí, Alejandro Navarro, Mathieu Léderlin, Xavier Serres, Jon Zugazagoitia, Sylvia Vetrhus, Magnus Jäderberg, Thomas B. Hansen, Victor Levitsky, Luis Paz‐Ares

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial

    Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial حسب Alice T. Shaw, Enriqueta Felip, Todd M. Bauer, Benjamin Besse, Alejandro Navarro, Sophie Postel‐Vinay, Justin F. Gainor, Melissa L. Johnson, Jörg Dietrich, Leonard P. James, Jill S. Clancy, Joseph Chen, Jean‐François Martini, Antonello Abbattista, Benjamin Solomon

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms

    Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal pap... حسب Yu, Jun, Sadakari, Yoshihiko, Shindo, Koji, Suenaga, Masaya, Brant, Aaron, Almario, Jose Alejandro Navarro, Borges, Michael, Barkley, Thomas, Fesharakizadeh, Shahriar, Ford, Madeline, Hruban, Ralph H, Shin, Eun Ji, Lennon, Anne Marie, Canto, Marcia Irene, Goggins, Michael

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study

    Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L... حسب Taofeek K. Owonikoko, H.R. Kim, Ramaswamy Govindan, Neal Ready, Martin Reck, Solange Peters, Shaker R. Dakhil, Alejandro Navarro, Jerónimo Rafael Rodríguez‐Cid, Michael Schenker, J.S. Lee, Vanesa Gutiérrez, Ivor Percent, Daniel Morgensztern, Justin Fairchild, Christine Baudelet, K. Park

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    1733P Analysis of chemotherapy (Ct) efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p)

    1733P Analysis of chemotherapy (Ct) efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p) حسب S. Cedrés, J.D. Assaf, Purificación Gómez, Ana Pérez, Nuria Pardo Aranda, Alejandro Navarro, Alex Martínez‐Martí, D.H. Marmolejo Castaneda, M.A. Rezqallah Aron, Anna Pedrola, Javier Gonzalo‐Ruiz, Joan Frigola, Caterina Carbonell, Ramon Amat, Rodrigo Dienstmann, Enriqueta Felip

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

    Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma حسب Aleix Prat, Alejandro Navarro, Laia Paré, Noemı́ Reguart, Patricia Galván, Tomás Pascual, Alex Martínez‐Martí, Paolo Nucíforo, Laura Comerma, Lluçia Alós, Núria Pardo, S. Cedrés, Cheng Fan, Joel S. Parker, Lydia Gaba, Iván Victoria, Núria Viñolas, Ana Vivancos, Ana Arance, Enriqueta Felip

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    DualMET andERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)

    DualMET andERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC) حسب Alex Martínez‐Martí, Enriqueta Felip, Judit Matito, Elisabetta Mereu, Alejandro Navarro, S. Cedrés, Núria Pardo, A. Martinez de Castro, Jordi Remón, Josep M. Miquel, Amy Guillaumet-Adkins, Ernest Nadal, Gustavo Rodríguez-Esteban, Oriol Arqués, Roberta Fasani, Paolo Nucíforo, Holger Heyn, Alberto Villanueva, Héctor G. Pálmer, Ana Vivancos

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

    Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study حسب Charles M. Rudin, Mark M. Awad, Alejandro Navarro, Maya Gottfried, Solange Peters, Tibor Csőszi, Parneet Cheema, Delvys Rodríguez‐Abreu, Mirjana Wollner, James Chih‐Hsin Yang, Julien Mazières, F. Orlandi, Alexander Luft, Mahmut Gümüş, Terufumi Kato, Gregory P. Kalemkerian, Yiwen Luo, Victoria Ebiana, M. Catherine Pietanza, Hye Ryun Kim

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer

    SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer حسب Charles M. Rudin, Stephen V. Liu, Ross A. Soo, Shun Lü, Min Hee Hong, Jong Seok Lee, Maciej Bryl, Daphne W. Dumoulin, Achim Rittmeyer, Chao‐Hua Chiu, Özgür Özyılkan, Melissa L. Johnson, Alejandro Navarro, Silvia Novello, Yuichi Ozawa, Sammi Hiu Tam, Namrata S. Patil, Xiaohui Wen, Meilin Huang, Tien Hoang, Raymond D. Meng, Martin Reck

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease

    Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease حسب Víctor Marcos‐Garcés, José Gavara, José V. Monmeneu, María P. López‐Lereu, María José Bosch, Pilar Merlos, N Pérez, César Ríos‐Navarro, Elena de Dios, Clara Bonanad, Paolo Racugno, Alejandro Navarro, Bruno Ventura Pérez, Jose Aguilar Botella, Silvia Mastrolembo Ventura, Luis Mainar, Joaquim Cànoves, Mauricio Pellicer, David Moratal, Gema Miñana, Julio Núñez, Francisco J. Chorro, Vicente Bodı́

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

    Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451 حسب Taofeek K. Owonikoko, Keunchil Park, Ramaswamy Govindan, Neal Ready, Martin Reck, Solange Peters, Shaker R. Dakhil, Alejandro Navarro, Jerónimo Rafael Rodríguez‐Cid, Michael Schenker, Jong Seok Lee, Vanesa Gutiérrez, Ivor Percent, Daniel Morgensztern, Carlos H. Barrios, Laurent Greillier, Sofia Baka, Miten Patel, Wen Lin, Giovanni Selvaggi, Christine Baudelet, Jonathan Baden, Dimple Pandya, Parul Doshi, Hye Ryun Kim

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study

    Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, control... حسب Michael Thomas, Santiago Ponce-Aix, Alejandro Navarro, Jorge Riera‐Knorrenschild, Manuel Schmidt, Emanuelly Varea Maria Wiegert, K. Kapp, B. Wittig, Claudia Mauri, M. Dómine Gómez, Jens Kollmeier, Parvis Sadjadian, K.-P. Fröhling, RM Huber, M. Wolf, Georg Pall, Veerle Surmont, Leon Bosquée, Paul Germonpré, W. Brückl, C. Grah, Christian Herzmann, Rumo Leistner, Andreas Meyer, Lothar Müller, Oliver Schmalz, Christian W. Scholz, Michael Schröder, Monika Serke, Claas Wesseler, Christian Brandts, Hans‐Georg Kopp, Wolfgang Blau, Frank Griesinger, M.R. García Campelo, Yolanda García García, Jose M. Pérez

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: